ST. LOUIS, Mo. (First Alert 4) - Missouri Attorney General Catherine Hanaway announced Monday she has sent a cease-and-desist letter to the drug manufacturer Eli Lilly.

The attorney general’s office says Eli Lilly has been imposing unlawful conditions on hospitals participating in the federal 340B Drug Pricing Program . Hanaway says Eli Lily created a policy that required hospitals to give them extensive and sensitive claims data to get cheaper medication.

The attorney general says that this policy effectively cut off the discounts for these facilities.

“Big Pharma does not get to bully Missouri hospitals or hold prescription drug prices hostage,” General Hanaway said. “Eli Lilly is abusing its market power to impose higher prescription prices in Missouri.…